-
1 Comment
CareNet, Inc is currently in a long term uptrend where the price is trading 42.7% above its 200 day moving average.
From a valuation standpoint, the stock is 86.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 9.4.
CareNet, Inc's total revenue rose by 88.9% to $2B since the same quarter in the previous year.
Its net income has increased by 24.9% to $250M since the same quarter in the previous year.
Based on the above factors, CareNet, Inc gets an overall score of 4/5.
Exchange | TSE |
---|---|
CurrencyCode | JPY |
ISIN | JP3277550004 |
Sector | Healthcare |
Industry | Health Information Services |
Market Cap | 31B |
---|---|
PE Ratio | 28.17 |
Target Price | 865 |
Beta | 1.73 |
Dividend Yield | 3.3% |
CareNet, Inc., together with its subsidiaries, engages in the pharmaceutical digital transformation and medical platform businesses in Japan. The company offers CareNet.com, a membership-based medical and healthcare information site for daily clinical practice; CareNeTV, a clinical medicine channel; PubMedCLOUD, a tool for searching and managing PubMed articles in Japanese; Doctors'Picks, a website where doctors gather medical news that they want other doctors to read; CareNet DVD, a clinical medical education DVD series; and CareNet Career, a service that introduces potential employers to meet the job changing and seeking needs of CareNet members, including doctors. It also provides medical institution management consulting; and health management support services. In addition, the company offers MR Plus, a service that distributes medical information from pharmaceutical companies to CareNet doctor members via the Internet; Web Lectures, a service that distributes live-streams lectures; Cancer @ Show-off, a service that provides medical information, particularly on surgical footage; and CRO, SMO, and CSO services. It serves pharmaceutical companies, doctors, and medical professionals. CareNet, Inc. was incorporated in 1996 and is based in Tokyo, Japan.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 2150.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025